SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950134-08-014148
Filing Date
2008-08-05
Accepted
2008-08-05 17:23:44
Documents
8
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d59031e10vq.htm 10-Q 564024
2 SEPARATION AGREEMENT- PETER LETENDRE d59031exv10w22.htm EX-10.22 80000
3 CONSULTING AGREEMENT- PETER LETENDRE d59031exv10w23.htm EX-10.23 27084
4 SEPERATION AGREEMENT- ROGER ECHOLS d59031exv10w24.htm EX-10.24 78843
5 CONSULTING AGREEMENT- ROGER ECHOLS d59031exv10w25.htm EX-10.25 26150
6 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER BY RULE 13A-14(A) d59031exv31w1.htm EX-31.1 9048
7 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER BY RULE 13A-14(A) d59031exv31w2.htm EX-31.2 9045
8 SECTION 1350 CERTIFICATION 1350 d59031exv32w1.htm EX-32.1 6472
  Complete submission text file 0000950134-08-014148.txt   802044
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 303-665-3450
REPLIDYNE INC (Filer) CIK: 0001180145 (see all company filings)

IRS No.: 841568247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52082 | Film No.: 08992372
SIC: 2834 Pharmaceutical Preparations